From October 8 to 10, 2019, the world's biggest annual medical industry event - the 2019 China Pharmaceutical Entrepreneurs' Scientist Congress and the 70th Anniversary of the founding of New China - was held at the Beijing Yanqi Lake International Convention and Exhibition Center. CMS has won three honors: ' Top 10 Most Invested Values of China Pharmaceuticals Listed Companies in 2019' 'China Pharmaceutical Innovation Company 100,' and 'Top 100 pharmaceutical industry benchmark enterprise of New China'.
The 2019 China Pharmaceutical Entrepreneurs' Scientist Congress is sponsored by the Chinese Association for the Management of Pharmaceutical Enterprises and the Chinese Association for the Biotechnology of Pharmaceuticals, and the Forum of 50 People Invested in the Medical and Health Industry of China (H50).Among the prizes awarded to CMS Pharmaceutical Industry, 'China Medical Listed Companies Have Top 10 Investment Values' has been selected for 11 consecutive years and is the wind marker for investment in the secondary market. The 100 companies representing the first group of pharmaceutical innovation strength in China were selected through a deep inventory of the current state of innovation in the pharmaceutical industry. The '70-year-old pharmaceutical industry benchmark enterprise' is jointly carried out by 20 leading industry associations, which have been chosen at different levels, resulting in 100 pharmaceutical enterprises with outstanding performance in social and public undertakings.
The three prizes are not only the recognition of the Chinese pharmaceutical industry on the investment value of CMS, but also highlight the Group's determination not to forget and continue to put more strength into the Chinese pharmaceutical innovation. In the future, the Group will continue to focus on the strategic core of innovation research and development to meet the unmet medical needs of the Chinese market through different levels of innovation, stages of development, and areas of innovation through layout!

Attachments

  • Original document
  • Permalink

Disclaimer

China Medical System Holdings Ltd. published this content on 14 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 October 2019 08:05:07 UTC